Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ProMIS Neurosciences
525
ProMIS Neurosciences
Technology
Biotechnology
We are a development stage biotech company harnessing the power of precision medicine to conquer Alzheimer’s disease and ALS.
Suggest edits
Type
B2b
Raised
$722.5k
Follow us
Also headquartered in Toronto
Robin
Ashley Madison
MaRS
Wattpad
Wealthsimple
LEAGUE
BMO
CPPIB
Ecobee
Polar
Companies in the same industry
Motus Therapeutics
CureVac AG
FDD Clinatec
Nohla Therapeutics
BlueRock Therapeutics
Spira
Dome
Therachon AG
GI Dynamics
Aurinia Pharmaceuticals
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$262,500
Grant - 2017
Canadian Institutes of Health Research
$460,000
Venture capital (Series UNDISCLOSED) - 2016
Team Size
1–10
Employees
I work here
Location
Toronto
,
Canada
Headquarters
Explore Toronto
the home of AI info
Stock under Close Observation: ProMIS Neurosciences (TSX:PMN)
the home of AI info
Hot Watch List: ProMIS Neurosciences (OTC:ARFXF)
the home of AI info
Stock Buzz: ProMIS Neurosciences (TSX:PMN)
the home of AI info
Stock Have a Latest Story: ProMIS Neurosciences (OTC:ARFXF)
the home of AI info
Stock under Close Observation: ProMIS Neurosciences (OTC:ARFXF)
the home of AI info
ProMIS Neurosciences Announces Fiscal Year 2019 Annual Results
the home of AI info
Why ProMIS Neurosciences, Inc.’s (TSE:PMN) CEO Pay Matters To You
the home of AI info
ProMIS Neurosciences Initiates Natural History Study of Blood-Based Biomarkers in Alzheimer’s …
the home of AI info
ProMIS Neurosciences Announces Gross Proceeds of $1257970 Related to the Exercise of …
the home of AI info
Can You Imagine How Chuffed ProMIS Neurosciences’s (TSE:PMN) Shareholders Feel About Its …
the home of AI info
ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference
the home of AI info
ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference
the home of AI info
ProMIS Neurosciences, Inc.
the home of AI info
ProMIS Neurosciences Inc.
the home of AI info
Is ProMIS Neurosciences, Inc. (TSE:PMN) Overpaying Its CEO?
the home of AI info
ProMIS Neurosciences to Participate in the BIO CEO & Investor Conference
the home of AI info
ProMIS Neurosciences Data for Alzheimer's Disease Program Targeting Tau Accepted for ...
the home of AI info
ProMIS Neurosciences Data for Alzheimer's Disease Program Targeting Tau Accepted for ...
the home of AI info
ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board
the home of AI info
ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum
